IJPRS

Home Abstract

Development and Validation of a Stability-indicating HPTLC Method for Analysis of Antiasthmatic Drugs


Received On: 03/04/2012
Accepted On: 05/04/2012


Author(s)

Nilam, P., Shirish, P., Dhara, P.


Author's Affiliation


Abstract

The objective of the present work was to develop a stability-indicating HPTLC method for Montelukast sodium (MTKT) and Levocetirizine dihydrochloride (LCTZ) in the presence of its degradation products generated from forced decomposition studies. Both drugs were subjected to acid, base, peroxide, and photo degradation. Successful separation of the drugs from the degradation products formed on aluminum-backed silica gel 60 F254 with Ethyl acetate: Methanol: Ammonia (7.0:1.4:0.7 v/v/v) as the mobile phase. Densitometric analysis of was performed at 231nm in concentration range 100-1200 ng/spot with range of recovery  99.91± 0.91%  for MTKT and  50-600 ng/spot with range of recovery 99.28± 0.51 % for LCTZ by the HPTLC method. Statistical analysis proved the method to be repeatable, specific, and accurate for estimation of MTKT and LCTZ. It can be used as a stability indicating method due to its effective separation of the drugs from its degradation products.


Keywords

RP-HPTLC, Levocetirizine dihydrochloride, Montelukast sodium, Stress conditions, validation

Cite This Article

Nilam, P., Shirish, P., Dhara, P. (2012). Development and Validation of a Stability-indicating HPTLC Method for Analysis of Antiasthmatic Drugs, International Journal for Pharmaceutical Research Scholars (IJPRS), 1(2), 8-16.


Recent Articles

Get FREE Updates for Upcoming
Pharma News, Jobs & Conferences

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

IJPRS will use the information you provide on this form to be in touch with you and to provide updates and marketing.